Health in Poland 1,085 indicators covering health for Poland. IndicatorLatest Year10-yr change Rank Causes of death - infant mortality by country of occurrence 902 2024 down 43.3% 8th Fetal, peri- and neonatal mortality rates by country of occurrence 2.8 2024 down 22.2% 25th Peri-neonatal mortality by age of mother, country of residence and 778 2024 down 42.2% 7th Proportion of bloodstream infection due to Escherichia coli resistant 20.1% 2023 up 20.7% 43rd Reported cases of gonorrhea 1,209 2023 up 120.2% 19th Reported cases of syphilis 2,986 2023 up 125.5% 7th Causes of death - potential years of life lost by treatable and 4,684 2023 down 12.5% 10th Treatable and preventable mortality of residents by cause and sex 124,398 2023 up 4.4% 4th Antimicrobial resistance or decreased susceptibiity (DS/R) to 40 2022 up 292.5% 6th Antimicrobial resistance or decreased susceptibiity (DS/R) to 15 2022 down 86.1% 44th Proportion of bloodstream infection due to methicillin-resistant 15.3% 2023 up 0.5% 37th Causes of death - infant mortality by country of residence 1,057 2023 down 37.3% 5th Financial hardship in health and components (SDG 3.8.2, 2025) 17.1% 2016 — 21st Reported cases of chlamydia 977 2023 up 140.6% 22nd Excess mortality by month -5.5 2026 down 111.0% 17th Consumption of antibiotics in the community and hospital sectors 22.6 2024 up 6.6% 9th Total use of antibacterials expressed as DDD per 1000 inhabitants per 23.97 2023 up 8.9% 15th Pattern of antibiotic consumption at national level 60.52 2023 down 1.7% 32nd Number of people spending more than 10% of household consumption or in 5,301,000.0% 2012 up 12.8% 9th Number of people spending more than 25% of household consumption or in 613,000.0% 2012 up 22.6% 9th Hospital days of in-patients - historical data 39.93 million 2021 up 67.5% 6th Number of people pushed below the $2.15 ($ 2017 PPP) poverty line by o 1,000 2012 down 83.3% 15th Number of people pushed below the $3.65 ($ 2017 PPP) poverty line by o 33,000 2012 down 54.2% 12th Hospital discharges by diagnosis, in-patients, total number 5.48 million 2021 up 59.6% 6th Hospital discharges by diagnosis, in-patients, per 100 000 14,510 2021 up 62.9% 13th Infant mortality by mother's educational attainment level (ISCED11f) 898 2024 — 7th Imports in 1000s hectolitres 332 2007 down 20.2% 20th Population with household spending on health greater than 25% of 1.1% 2013 down 21.5% 28th Hospital discharges by diagnosis, day cases, total number 2.27 million 2021 up 146.2% 5th Population pushed below a relative poverty line by household health 3.1% 2013 down 3.7% 13th Increase in poverty gap due to household health expenditures 0.8% 2013 down 13.7% 13th Number of isolates tested for ceftriaxone 23 2020 down 17.9% 43rd Proportion of isolates with decreased susceptibility or resistance 0 2020 — 13th Hospital discharges by diagnosis, day cases, per 100 000 inhabitants 6,010 2021 up 151.3% 12th Population pushed below the $3.20 a day poverty line by household 0.1% 2013 down 55.6% 30th Increase in poverty gap due to household health expenditures 0.0% 2013 down 75.0% 32nd Increase in poverty gap due to household health expenditures 0.0% 2013 down 83.3% 31st Population pushed below the $1.90 a day poverty line by household 0.0% 2013 down 100.0% 28th Increase in poverty gap due to household health expenditures 0.0% 2013 — 26th Population pushed below the $2.15 a day poverty line by household 0.0% 2013 down 100.0% 26th Increase in poverty gap due to household health expenditures 0.0% 2013 — 25th Population pushed further below the $3.20 a day poverty line by 0.2% 2013 down 63.3% 33rd Population pushed below the $3.65 a day poverty line by household 0.1% 2013 down 84.4% 32nd Population pushed further below the $3.65 a day poverty line by 0.3% 2013 down 66.7% 31st Proportion of isolates with resistance to azithromycin reported to 34.8 2020 up 224.8% 1st Number of isolates tested for azithromycin 23 2020 down 17.9% 41st Households with out-of-pocket payments greater than 40% of capacity 9.4% 2021 down 1.2% 13th Proportion of isolates with resistance to ciprofloxacin reported to 50.7 2018 down 21.1% 38th Number of isolates tested for ciprofloxacin 73 2018 up 160.7% 38th Proportion of isolates with decreased susceptibility or resistance 1.4 2018 — 16th Number of isolates tested for extended-spectrum cephalosporins 73 2018 up 160.7% 38th Proportion of children at the end of lower secondary achieving at 82.8% 2015 up 3.3% 16th Exports of beer (barley) in 1000s hectolitres 1.62 2009 down 99.0% 81st Proportion of isolates with decreased susceptibility or resistance 1.4 2018 — 10th Number of isolates tested for cefixime 73 2018 up 160.7% 20th Availability of estimates on large health expenditures as a share of 1 2012 unchanged 1st Availability of estimates on impoverishment due to out-of-pocket 1 2012 unchanged 1st Civil registration coverage of cause-of-death 100.0% 2012 up 0.6% 1st Alcohol-related road traffic crashes with fatalities 13.3% 2011 up 72.7% 19th Alcohol-related road traffic crashes with fatalities 13.3% 2011 up 72.7% 19th ← Previous Page 18 of 19 Next →